ASX: ALA Arovella Therapeutics Limited ACN 090 987 250 ASX RELEASE 22 October 2026 AROVELLA R&D TAX REBATE OF $4.03 MILLION Arovella Therapeutics Ltd (ASX: ALA) ACN 090 987 250 (Arovella or the Company) is pleased to announce that it has received an FY2026 R&D Tax Incentive refund of $4.03 million....